1. Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma

   • Bakiye Goker Bagca
   • Cigir Biray Avci
   • Halil Bulent Karci

   Correction 02 March 2022 Article: 85

2. How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China

   • Yongkai Lu
   • Ruijuan Chen
   • Yi Li

   Letter to the Editor 23 February 2022 Article: 79

   

3. DNA methylation marker to estimate ovarian cancer cell fraction

   • Takahiro Ebata
   • Satoshi Yamashita
   • Toshikazu Ushijima

   Original Paper 23 February 2022 Article: 78

   

4. In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells

   • Archana A. Gupta
   • Supriya Kheur
   • Vikrant R. Patil

   Original Paper 23 February 2022 Article: 77

   

5. Innovation in cancer therapeutics and regulatory perspectives

   • Pinky Sharma
   • Vikas Jhawat
   • Rohit Dutt

   Review Article 23 February 2022 Article: 76

   

6. Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care

   • Eleonora Pinto
   • Rita Alfieri
   • Gian Piero Turchi

   Perspectives in Oncology 23 February 2022 Article: 75

7. Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA

   • Esther Ro
   • Vivian Vu
   • Yudan Wei

   Original Paper 28 April 2022 Article: 69

   

8. Oncotype DX testing does not affect clinical practice in stage IIa colon cancer

   • Benjamin G. Allar
   • Evangelos Messaris
   • Thomas E. Cataldo

   Original Paper 12 February 2022 Article: 59

   

9. Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth

   • Kanako Yokomizo
   • Kayoko Waki
   • Akira Yamada

   Original Paper Open access 12 February 2022 Article: 58

   

10. In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity

    • Reza Hashemi
    • Maryam Peymani
    • Hana Saffar

    Original Paper 12 February 2022 Article: 57

    

11. Management of oligoprogression in non-small cell lung cancer patients

    • Alfredo Tartarone
    • Rosa Lerose
    • Marina Tartarone

    Review Article 12 February 2022 Article: 56

12. Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma

    • Hua Zhang
    • Jintong Chen
    • Siqing Wang

    Original Paper Open access 12 February 2022 Article: 55

    

13. Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions

    • Maryana Teufelsbauer
    • Clemens Lang
    • Gerhard Hamilton

    Original Paper Open access 12 February 2022 Article: 54

    

14. In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma

    • Somnath Ghosal
    • Subrata Banerjee

    Original Paper 12 February 2022 Article: 53

    

15. Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells

    • Jianjian Zhuang
    • Liping Xia
    • Juxin Yin

    Original Paper 12 February 2022 Article: 52

    

16. ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma

    • Guoxin Hou
    • Zhimin Lu
    • Xinmei Yang

    Original Paper 12 February 2022 Article: 51

    

17. Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress

    • Ekjot Kaur
    • Madhura Ketkar
    • Shilpee Dutt

    Short Communication 12 February 2022 Article: 50